{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075724","form_type":"8-K","ticker":"GPCR","cik":"0001888886","company_name":"Structure Therapeutics Inc.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.101751+00:00","generated_at":"2026-06-01T01:11:13.420245+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Structure Therapeutics elects Sharon Tetlow to board; Ted Love joins audit committee","bullets":["Sharon Tetlow elected as Class I director for 3-year term with 117.2M votes for, 12.6M against.","Shareholders ratified Ernst & Young as independent auditor for FY2024 (129.9M for, 32k against).","Ted W. Love, M.D. appointed to Audit Committee effective June 25, 2024.","Audit Committee now consists of Sharon Tetlow, Eric Dobmeier, and Dr. Love."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075724","json":"https://secwatch.observer/filing/0001104659-24-075724.json","markdown":"https://secwatch.observer/filing/0001104659-24-075724.md","text":"https://secwatch.observer/filing/0001104659-24-075724.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1888886/000110465924075724/0001104659-24-075724-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1888886/000110465924075724/tm2418268d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:11:13.420245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}